AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis
about
Prevention of Ovarian Hyperstimulation Syndrome: A ReviewIndividualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practiceThe ovarian reserve of primordial follicles and the dynamic reserve of antral growing follicles: what is the link?The ageing ovary and uterus: new biological insightsAnalysis of ovarian reserve markers (AMH, FSH, AFC) in different age strata in IVF/ICSI patientsWhich cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation and in vitro fertilization success? A prospective data analysis.Is AMH Level, Independent of Age, a Predictor of Live Birth in IVF?ABO blood group and ovarian reserve: a meta-analysis and systematic review.The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropinFollicle-stimulating hormone receptor (FSHR) alternative skipping of exon 2 or 3 affects ovarian response to FSHPrognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocolSerum antimüllerian hormone measurements with second generation assay at two distinct menstrual cycle phases for prediction of cycle cancellation, pregnancy and live birth after in vitro fertilization.Female reproductive decline is determined by remaining ovarian reserve and age.Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone and antral follicle count measurements: a retrospective study.Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.The physiology and clinical utility of anti-Mullerian hormone in women.The predictive accuracy of anti-Müllerian hormone for live birth after assisted conception: a systematic review and meta-analysis of the literature.The use of ovarian reserve markers in IVF clinical practice: a national consensus.Clinical impact of LH rises prior to and during ganirelix treatment started on day 5 or on day 6 of ovarian stimulation.Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis.To what extent does Anti-Mullerian Hormone contribute to a better prediction of live birth after IVF?Prediction of reproductive outcomes according to different serum anti-Müllerian hormone levels in females undergoing intracystoplasmic sperm injectionIntraovarian control of early folliculogenesisIndividualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients.Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.Ovarian reserve testsCut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome.The value of anti-Mullerian hormone measurement in the long GnRH agonist protocol: association with ovarian response and gonadotrophin-dose adjustments.Optimal cutoff value of basal anti-mullerian hormone in iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation.C-type natriuretic peptide stimulates ovarian follicle development.Serum anti-Mullerian hormone levels correlate with ovarian response in idiopathic hypogonadotropic hypogonadism.Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment.Measurement of antral follicle count in patients undergoing in vitro fertilization treatment: results of a worldwide web-based survey.Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.Ovarian reserve markers in unexplained infertility patients treated with clomiphene citrate during intrauterine insemination.Correlation between three assay systems for anti-Müllerian hormone (AMH) determinationAssessment of the Access AMH assay as an automated, high-performance replacement for the AMH Generation II manual ELISA.A new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulationIndividualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count.Advancement in the treatment of diminished ovarian reserve by traditional Chinese and Western medicine.
P2860
Q26828442-09D47DB9-9BF0-4A58-A15B-2076650D7AE9Q26829747-0EFC977A-1B9D-4B8D-B119-6F8F40E90C5AQ27024729-317E1D73-D6D8-4854-A140-908718B5B7EBQ28278102-C6D158E5-C822-41D8-97F8-BC22969331E4Q28831019-59323B35-A957-4344-842D-E8AF80AEC507Q30766464-A1560712-6AD3-4E1C-8C42-BFCD0BF2A38DQ33604947-4E47CE38-7BFD-43A2-8301-902EEA447C5FQ33648972-CD587536-208D-4905-B53E-63A7310C1C4FQ33761614-94F91E72-7999-4352-9052-8BD15A82FE80Q33810850-8877984B-D640-4C91-A805-7E9A5B27131CQ33888265-A60B2932-00A2-43D0-AA46-109B5D525E12Q34226385-1C6906D6-FD2A-48E2-A24D-E56F1EFD73A3Q34331507-4BAC373C-9DB3-4EF8-A566-A8AC93B6C629Q34337552-9C299ED0-F1CD-401F-8063-F63F22DB8460Q34392414-DBC204E3-560E-4855-B607-A43027887D14Q34398233-232C4DF2-F890-4576-B048-C503672540EDQ34404612-C4D92A72-15AC-49D6-9519-70DA8D05196BQ34500365-7E0CD3AF-5603-49A4-A260-F05CE4DB8BF7Q34656033-09277201-91F7-4A28-83D6-5917D3ACF24BQ34700094-E12BAB09-03BB-4B29-B540-D8972D43249CQ34962726-3BE6AD17-ED17-4CA4-B442-698EC0AE62E8Q34999705-A3A2AB4B-E598-465A-AB16-81B736584D3AQ35024088-AD47ED7F-6BE2-421B-9589-43F9083B4161Q35147438-FFE4C40E-FB78-47D4-8271-445F650C2254Q35621462-1D0F6D12-6C3E-465E-BFE0-3F76B9D4BB04Q35749173-CDF53B7D-B062-4135-BB1C-83601A4F4852Q35898934-AC4FF536-7C89-4F2E-A8DB-257953D038CBQ35976287-5755D384-C120-4BA3-A63C-31A407FCAC19Q36045426-9694BF65-64A8-4DCA-B724-8C352CE423BDQ36065498-C140CCC7-25C8-4BE7-A423-AFF17E72A588Q36106370-A2DA25D5-7550-49B4-869A-D50956AF9987Q36112513-779F9F99-86B2-4550-8291-67B352D190FAQ36192094-352CD26F-DE57-4580-9944-849CE0B7AD42Q36234933-EF2119CB-9F12-49A3-BF7F-B4BD2ADD4C1BQ36418952-0F409D71-2E5E-4BA7-91AE-CE574D808437Q36484685-2DF4A0EC-C74E-4BFF-9CB0-46C91E2AE6D4Q36584093-517938D2-B7ED-453A-A8E0-9B5B30860733Q36594368-328521D7-344D-4ADD-B9F0-CD78B9117ADDQ36599421-97A240B6-F0B4-4CF0-B78D-1BCA929ADB85Q36740940-1A6FCD8C-7DC5-4EB4-B388-CEF97E58BA7A
P2860
AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
AMH and AFC as predictors of e ...... erstimulation: a meta-analysis
@ast
AMH and AFC as predictors of e ...... erstimulation: a meta-analysis
@en
AMH and AFC as predictors of e ...... erstimulation: a meta-analysis
@nl
type
label
AMH and AFC as predictors of e ...... erstimulation: a meta-analysis
@ast
AMH and AFC as predictors of e ...... erstimulation: a meta-analysis
@en
AMH and AFC as predictors of e ...... erstimulation: a meta-analysis
@nl
prefLabel
AMH and AFC as predictors of e ...... erstimulation: a meta-analysis
@ast
AMH and AFC as predictors of e ...... erstimulation: a meta-analysis
@en
AMH and AFC as predictors of e ...... erstimulation: a meta-analysis
@nl
P2093
P2860
P3181
P356
P1476
AMH and AFC as predictors of e ...... erstimulation: a meta-analysis
@en
P2093
B C Fauser
B C Opmeer
F J M Broekmans
M Dólleman
P2860
P3181
P356
10.1093/HUMUPD/DMQ034
P407
P577
2011-01-01T00:00:00Z